Repurposing CD8+ T cell immunity against SARS-CoV-2 for cancer immunotherapy: a positive aspect of the COVID-19 pandemic?
oleh: Shashi Gujar, Jonathan G. Pol, Youra Kim, Guido Kroemer
| Format: | Article |
|---|---|
| Diterbitkan: | Taylor & Francis Group 2020-01-01 |
Deskripsi
The COVID-19 pandemic has afflicted most countries on the planet. As a result, immunity against SARS-CoV-2, induced via natural infections or imminent vaccinations, is expected to develop in a large fraction of the global population. Here, we propose to exploit SARS-CoV-2-specific CD8+ T cells for cancer immunotherapy strategies.